AstraZeneca announced that it would forego profit for as long as the pandemic endured. But Pfizer continued to pursue the same model that had supplied its CEO, Albert Bourla, with a pay package reaching $21 million in 2020. The company charged as much as the market would bear. Bourla was another signatory to the Business Roundtable’s stakeholder capitalism pledge. Yet his company was catering to shareholders above any sense of civic responsibility.
